U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316608) titled 'A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults' on Dec. 19, 2025.
Brief Summary: The purpose of this study is to assess how well laroprovstat and rosuvastatin combined in a single tablet to be taken by mouth works compared with laroprovstat and rosuvastatin individual tablets taken by mouth (relative bioavailability) in healthy adults.
Study Start Date: March 16
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Laroprovstat Dose X/Rosuvastatin Dose 1 FCDP test fo...